Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market

Berlinhopkin03 Aug, 2022Business

For decades, treatment options were limited to splenectomy and corticosteroids, followed by the plasma-derived treatments. However, as biology improves, an expanded treatment repertoire is emerging for the ITP disease. Many companies are investing the research and development for the launching novel treatment for ITP. Current research and development activities are mainly focusing on combining therapies to address multiple mechanisms of disease simultaneously. Additionally, as the complex pathophysiology of ITP improves, novel therapies targeting alternative pathways are becoming available.